Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
71.00    1.00 (1.43%)
Bid:
70.00
Ask:
72.00
Spread: 2.00 (2.857%)
Market Cap: £323.13m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Avacta Group News

First patient dosed in Avacta's 'AVA6000' trial
11 Aug 2021

First patient dosed in Avacta's 'AVA6000' trial

(Sharecast News) - Clinical-stage oncology drug company Avacta Group announced on Wednesday that the first patient has been dosed in its phase 1 multi...

IN BRIEF: Shipment of Avacta's Covid-19 lateral flow test starts
4 Aug 2021

IN BRIEF: Shipment of Avacta's Covid-19 lateral flow test starts

IN BRIEF: Shipment of Avacta's Covid-19 lateral flow test starts

AIM WINNERS & LOSERS: Tern raises GBP6 million; Kromek revenue down
14 Jul 2021

AIM WINNERS & LOSERS: Tern raises GBP6 million; Kromek revenue down

AIM WINNERS & LOSERS: Tern raises GBP6 million; Kromek revenue down

IN BRIEF: Avacta wins manufacturer certification for lateral flow test
14 Jul 2021

IN BRIEF: Avacta wins manufacturer certification for lateral flow test

IN BRIEF: Avacta wins manufacturer certification for lateral flow test

Avacta gets ISO certification for Affirmer manufacture and distribution
14 Jul 2021

Avacta gets ISO certification for Affirmer manufacture and distribution

(Sharecast News) - Diagnostics and cancer therapies developer Avacta announced on Wednesday that its life sciences diagnostics division has achieved I...

IN BRIEF: Avacta's lateral flow test detects Covid Delta variant
29 Jun 2021

IN BRIEF: Avacta's lateral flow test detects Covid Delta variant

IN BRIEF: Avacta's lateral flow test detects Covid Delta variant

AIM WINNERS & LOSERS: Avacta virus test works; React virus boost ebbs
29 Jun 2021

AIM WINNERS & LOSERS: Avacta virus test works; React virus boost ebbs

AIM WINNERS & LOSERS: Avacta virus test works; React virus boost ebbs

Avacta rapid Covid-19 test detects Delta variant in study
29 Jun 2021

Avacta rapid Covid-19 test detects Delta variant in study

(Sharecast News) - Diagnostics and cancer therapies developer Avacta Group announced on Tuesday that a study has shown that its 'AffiDX' antigen later...